U.S. markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.26 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.14 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.04
    -1.53 (-2.86%)
     
  • Gold

    1,827.70
    -23.70 (-1.28%)
     
  • Silver

    24.83
    -0.97 (-3.77%)
     
  • EUR/USD

    1.2085
    -0.0071 (-0.58%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • GBP/USD

    1.3583
    -0.0108 (-0.79%)
     
  • USD/JPY

    103.8000
    -0.0160 (-0.02%)
     
  • BTC-USD

    35,223.11
    +222.45 (+0.64%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • FTSE 100

    6,735.71
    -66.25 (-0.97%)
     
  • Nikkei 225

    28,519.18
    -179.08 (-0.62%)
     

Benzinga Pro's Top 5 Stocks To Watch For Fri., Mar. 13, 2020: GLD, OPK, IBIO, CPB, CANF

Benzinga Newsdesk
·1 min read

Benzinga Pro's Stocks To Watch For Friday

  • SPDR Gold Shares (GLD) - Gold has not been serving as a store of value during this week's market rout. While the S&P 500 has been down about 5%, gold has been down about 6%. With the S&P 500 futures hitting a limit-up breaker Friday morning (up ~5%), gold is up about 0.7%.

  • OPKO Health (OPK) - Shares were up 50% Friday following a 15% decline Thursday. New York Governor Cuomo said the State is contracting with the company's BioReference Laboratories unit to run 5,000 tests/day for coronavirus. Additionally, the company announced its BioReference Labs is now accepting specimens for testing coronavirus from healthcare providers throughout the US.

  • iBio (IBIO) - The stock was up 30% after the company filed four provisional patent applications for its virus-like particle platform technology in conjunction with FastPharming System for treating and preventing coronavirus infection.

  • Campbell Soup (CPB) - Shares were up about 3% to around $49 with the broader markets despite a Goldman Sachs downgrade to Sell. The firm set a $47 price target. 

  • Can-Fite (CANF) - The company announced it will explore anti-coronavirus effects of its piclidenoson in collaboration with Lewis Katz School of Medicine. The stock was up about 20%.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.